Clinical Trial Update: Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating phenylacetate in children with recurrent or progressive brain tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors

Drugs mentioned

• Phenylacetate (phenylacetate)

Snippet

Sponsor: Texas Children's Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED